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The nucleotide-binding domain and leucine-rich-
repeat-containing (NLR) family of pattern-recogni-
tion molecules mediate host immunity to various
pathogenic stimuli. However, in vivo evidence for the
involvement of NLR proteins in viral sensing has not
been widely investigated and remains controversial.
As a test of the physiologic role of the NLR molecule
NLRP3 during RNA viral infection, we explored the
in vivo role of NLRP3 inflammasome components
during influenza virus infection. Mice lacking Nlrp3,
Pycard, or caspase-1, but not Nlrc4, exhibited dra-
matically increased mortality and a reduced immune
response after exposure to the influenza virus.
Utilizing analogs of dsRNA (poly(I:C)) and ssRNA
(ssRNA40), we demonstrated that an NLRP3-medi-
ated response could be activated by RNA species.
Mechanistically, NLRP3 inflammasome activation
by the influenza virus was dependent on lysosomal
maturation and reactive oxygen species (ROS). Inhi-
bition of ROS induction eliminated IL-1b production
in animals during influenza infection. Together, these
data place the NLRP3 inflammasome as an essential
component in host defense against influenza infec-
tion through the sensing of viral RNA.
INTRODUCTION
Innate immune responses to influenza and other pathogens
typically involve a highly conserved host-cell signaling mecha-
nism designed to protect the host and get rid of harmful
microbes. Recognition of conservedmicrobial structures, known
as pathogen-associated molecular patterns (PAMPs) within cells
of a myeloid origin is a hallmark feature of adequate host immu-
nity. PAMPs are recognized by pattern-recognition receptors or
sensors (PRRs), which subsequently initiate signaling cascades
resulting in the production of proinflammatory cytokines and
type-I interferons. Thus far, three families of PRRs, including
556 Immunity 30, 556–565, April 17, 2009 ª2009 Elsevier Inc.the RLHs (RIG-I-like helicases), TLRs (toll-like receptors), and
NLR (nucleotide-binding domain and leucine-rich-repeat-
containing) proteins, have been identified and shown to be acti-
vated in response to viral pathogens (Akira et al., 2006; Ting
et al., 2008). The individual members of these families can be
distinguished by ligand specificity, cellular localization, and acti-
vation of unique downstream signaling pathways. The strategy
of employing multiple families of PRRs affords the host a high
degree of functional redundancy and provides multiple mecha-
nisms to optimally respond to a diverse range of pathogens
(Kawai and Akira, 2007).
The NLR proteins are emerging as a major route by which the
innate immune system responds to microbial pathogens.
Substantial evidence suggests that the NLR proteins serve as
intracellular mediators of PAMP-initiated host-cell signaling,
although the exact mechanisms underlying NLR responses to
pathogens are not completely understood. One of the funda-
mental reactions of the innate immune response to viral infection
is the processing and release of proinflammatory cytokines,
including the regulation and release of IL-1b. It has been demon-
strated that the NLR protein NLRP3, together with its adaptor
protein, PYD- and CARD-domain-containing protein (PYCARD)
(which is also known as Apoptotic Speck protein containing
a CARD [ASC]), regulates IL-1bmaturation through the formation
of a biochemical complex called the inflammasome (Agostini
et al., 2004). This inflammasome regulates the activation of cas-
pase-1 and subsequent cleavage of the IL-1b and IL-18 precur-
sors into their functional forms, which are then released from the
cell. In addition to NLRP3, other NLR proteins, such as NLRC4
and NLRP1, also cause caspase-1 activation and IL-1b produc-
tion (Mariathasan and Monack, 2007).
Although the function of the NLRP3 inflammasome in medi-
ating responses to bacterial pathogens has been studied by
several groups, the in vivo function of this important signaling
complex during the course of viral infection is not well under-
stood. In vitro transfection of DNA from viruses, bacteria, or
mammalian sources into macrophages activates the NLRP3 in-
flammasome, but this result would suggest a global response
to DNA rather than an antiviral response (Muruve et al., 2008).
One report has shown that a synthetic analog of dsRNA, poly(I:C)
activates IL-1b through the NLRP3 pathway (Kanneganti et al.,
2006). However, another group failed to replicate this finding
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Pathways
(A and B) The survival of Pycard/and Casp1/ mice was measured and compared to wild-type (A) and Myd88/ (B) mice (*p < 0.05; log rank). Mock-
inoculated (n = 7); influenza-infected wild-type (n = 19); Myd88/ (n = 11); Pycard/ (n = 12); and Casp1/ (n = 7).
(C) Lungs were harvested 3 days after infection. Sections through the main bronchiole of the left lobe were stained with H&E.
(D) Histological scoring of H&E-stained lung sections as shown in (C) (*p < 0.05; **p < 0.01; mean ± SEM).Wild-type (n = 8);Myd88/ (n = 7);Pycard/ (n = 6); and
wild-type mock-infected (n = 4). Results are representative of at least two independent experiments.(Muruve et al., 2008). Thus, the role of NLRP3 and the inflamma-
some during viral infection remains unresolved. Equally impor-
tant, the majority of NLR characterization has been based on
in vitro or ex vivo data generated from human cell lines and
primary mouse cells. Although these studies have provided
a wealth of information, the underlying relevance of these
proteins in actual pathogenesis and host defense against patho-
gens in vivo has been much less defined.
To assess the contribution of NLR inflammasomes in viral
pathogenesis, we assessed the host response to the influenza
A virus. Influenza infection results in a highly contagious respira-
tory illness leading to substantial morbidity and occasionally
death. Annual epidemics typically affect 5%–15% of the popula-
tion and are thought to result in 250,000–500,000 deaths annu-
ally. Of the three types of influenza viruses, influenza A viruses
are the most virulent to humans and are capable of infecting
multiple mammalian and avian species. Human influenza A
viruses can be further divided into different serotypeson the
basis of the antibody response to the viral surface glycoproteins,
hemagglutinin (HA) and neuraminidase (NA). The influenza A
virus genome is composed of eight individual strands of ssRNA,
which encode a total of 11 different proteins.
In this report, we show that the NLRP3 inflammasome has
a profound influence on in vivo host immune response and
survival after airway infection with a mouse-adapted influenza
A virus. Utilizing in vivo challenges with a synthetic analog of
dsRNA, we demonstrated a possible mechanism underlying
the NLRP3-associated innate immune response to viruses
involved in the recognition of viral RNA. Furthermore, we
extended the relevancy of these findings to human cells by es-
tablishing that ssRNA, dsRNA, and influenza A virus-mediated
IL-1b release by human monocytes was dependent on the
NLRP3 inflammasome and relied on intact lysosomal function,lysosomal enzymes such as cathepsin B, and reactive oxygen
species (ROS). This report demonstrates that the NLRP3 inflam-
masome is an essential component of the in vivo host immune
response to viral infection in a model system that is physiologi-
cally relevant to human disease.
RESULTS
Loss of NLR Inflammasome Activity Alters Survival
and Inflammation in Response to the Influenza Virus
To assess the in vivo physiological contribution of NLR and TLR
signaling pathways in response to influenza virus infection, we
utilized gene-deletion mice in an influenza A/PR/8/34 virus infec-
tion model. Previous studies utilizing mouse primary macro-
phages have demonstrated that NLR components are necessary
for IL-1b release in response to influenza virus infection in culture
(Kanneganti et al., 2006). However, the in vivo physiological
relevance of these findings has yet to be explored extensively.
To assess the contribution of NLR inflammasomes in mouse
survival and inflammation, we assessed mice deficient in either
the NLR adaptor protein ASC (Pycard/) or caspase-1
(Casp1/). Mice lacking these inflammasome components
showed significantly increased mortality after influenza infection
(Figure 1A). As a comparison and as a control, we included the
Myd88/ mice. Previous studies have demonstrated that
TLR3, 7, 8, and 9 represent the subset of TLRs that recognize
viral nucleic acids andmediate the induction of type-I IFN (Kawai
and Akira, 2007; Koyama et al., 2007). TLR7, 8, and 9 are depen-
dent upon the TLR adaptor protein MyD88 for proper signal
transduction. However, mouse survival was only moderately
decreased for Myd88/ animals, suggesting that removal of
MyD88 and the disruption of the associated TLR7, 8, and 9Immunity 30, 556–565, April 17, 2009 ª2009 Elsevier Inc. 557
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Figure 2. The Nlrp3 Inflammasome Is Required for Survival and
Mediates Airway Inflammation and Viral Clearance after Pulmonary
Challenge with Influenza Virus
(A) The survival of Nlrp3/and Nlrc4/mice was measured and compared to
that of the wild-type (**p < 0.01; log rank). Wild-type mock-infected (n = 7);
wild-type infected (n = 19); Nlrp3/ infected (n = 16); and Nlrc4/ infected
(n = 7). All survival experiments were performed together with those in Figure 1,
therefore, the wild-type controls are identical to those shown in Figure 1.
(B) Histological scoring of H&E-stained lung sections as shown in (C) (*p < 0.05;
**p < 0.01; mean ± SEM).
(C) Lungs were harvested 3 dpi. Sections through the main bronchiole of the
left lobe were stained with H&E.
(D) Bronchoalveolar lavage (BAL) was performed, and the total number of cells
present in the bronchoalveolar lavage fluid (BALF) was calculated (*p < 0.05;
**p < 0.01; mean ± SEM).
(E) BALF cellular composition was determined via differential staining, and
subpopulations were assessed via FACS. Wild-type influenza-infected (n = 8);
Nlrp3/ (n = 5); Nlrc4/ (n = 3); Pycard/ (n = 6); wild-type mock-infected
(n = 4). Results are representative of three independent experiments.
(F) The number of monocytes, neutrophils, and lymphocytes was determined
via differential staining of BALF cells (*p < 0.05; mean ± SEM). Wild-type influ-
enza-infected (n = 8);Nlrp3/ (n = 4);Nlrc4/ (n = 4); wild-typemock-infected
(n = 5).
(G) Influenza viral titers were determined by standard plaque assay either 3 or
7 dpi (*p < 0.05; mean ± SEM). Wild-type mock-infected, day 3 (n = 3);
wild-type influenza-infected, day 3 (n = 9); Nlrp3/ influenza-infected, day 3
(n = 9); wild-type mock-infected day 7 (n = 4); wild-type influenza-infected,
day 7 (n = 6); and Nlrp3/ influenza-infected, day 7 (n = 7).558 Immunity 30, 556–565, April 17, 2009 ª2009 Elsevier Inc.signaling cascades only modestly affect mouse survival
(Figure 1B).
To assess the extent of inflammation, we euthanized mice
3 days post-inoculation (dpi) and harvested the lungs for
histology (Figure 1C). We observed a marked increase in airway
inflammation, characterized by enhanced macrophage and
neutrophil influx into the airways, 3 dpi. in wild-type and
Myd88/ mice as compared to the mock-inoculated wild-
type. In contrast, the infected Pycard/ and Casp1/ (not
shown) mice demonstrated substantially reduced airway inflam-
mation. Histology scoring, by a blinded reviewer, confirmed the
significant attenuation of airway inflammation in the Pycard/
mice (Figure 1D). Together, these data demonstrate that both
Pycard and Casp1, but not Myd88, are required for mouse
survival and mediate airway inflammation in response to influ-
enza virus infection.
The Nlrp3 Inflammasome Is Required forMouse Survival
and Inflammation after Influenza Infection
The above data suggest that proper activation of an NLR inflam-
masome is necessary for host survival and for mediating the
innate immune response after influenza virus infection. It is well
established that the NLR protein, NLRP3, can form an inflamma-
some complex with PYCARD and caspase-1 in response to
a plethora of stimuli (Eisenbarth et al., 2008; Li et al., 2008;
Martinon et al., 2006; Sutterwala et al., 2006). In addition to
NLRP3, other NLRs such as NLRC4 have been suggested to
form an NLRP3-independent inflammasome that functions in
IL-1b maturation in response to Salmonella typhimurium and
Pseudomonas aeruginosa infection (Mariathasan et al., 2004;
Miao et al., 2008). After influenza inoculation, all animals demon-
strated a decrease in bodyweight (Figure S1 in the Supplemental
Data). However, as seen in Figure 2A, a dramatic decrease in
survival was observed in Nlrp3/ mice after virus infection,
and no differences in mortality were observed between Nlrc4/
and wild-type mice. Interestingly, the removal of Nlrp3 produced
a more dramatic effect on animal survival than the removal of
Pycard or caspase-1, suggesting the possibility that Nlrp3 might
exert biologic effects in addition to caspase-1 activation;
however, this remains to be explored.
As observed with the Pycard/ animals, Nlrp3/ mice show
a significant decrease in airway inflammation after influenza
infection. Histology scoring revealed no increase in inflammation
in mock-infected animals, and only a modest increase was
observed in the Nlrp3/ mice, whereas a significant increase
in airway inflammation was observed in the Nlrc4/ and wild-
type animals (Figure 2B). Histopathology assessments revealed
a mild increase in airway inflammation in virus-infected Nlrp3/
mice compared to mock-infected mice, but they revealed an
exacerbated increase in Nlrc4/ and wild-type animals 3 dpi
(Figure 2C). To further characterize the composition of the cell
populations infiltrating the airways during viral infection, we har-
vested bronchoalveolar lavage fluid (BALF) and assessed cellu-
larity. Consistent with the histology findings, Nlrp3/ animals
demonstrated a significant decrease in total BALF cellularity
when they were compared to either the Nlrc4/ or wild-type
animals (Figure 2D). Analysis of BALF cellularity indicates that
macrophages and neutrophils represent the bulk of infiltrating
cells in response to influenza. Differential profiling revealed no
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BALF between genotypes (Figure 2E); however, the Nlrp3/
mice demonstrated an overall decrease in the number of mono-
cytes and granulocytes (Figure 2F). Together, this indicates that
the Nlrp3 inflammasome is an essential mediator of in vivo
inflammatory responses to influenza virus.
We have observed that Nlrp3/ animals show reduced
immune responses after influenza challenge. To determine
whether this reduction resulted in a defect in viral clearance,
we harvested lungs from wild-type and Nlrp3/ mice 3 and
7 dpi. During the early stages of infection (3 dpi), all influenza-
challenged mice demonstrated an increase in viral titer, and no
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Figure 3. Nlrp3 Inflammasome Components Are Highly Expressed
in Myeloid Cells and in the Lungs during Influenza A Virus Infection
(A and B) Pycard (A) and Nlrp3 (B) gene expression was assessed in primary
mouse bone-marrow-derived macrophages (Macs), B cells, T cells, mouse
airway epithelial cells (MAECs), and mouse embryonic fibroblasts (MEFs) by
RT-PCR; samples were normalized to 18 s and standardized to expression
in MEFs. Each cell line was assessed in triplicate, and data are representative
of three independent experiments.
(C and D) IL-1b, Nlrp3, and Nlrc4 transcripts were assessed by RT-PCR,
normalized to 18 s, and standardized to naive levels after virus infection in
primary mouse bone-marrow-derived macrophages (BMMs) (C) and MAECs
(D) (*p < 0.05; mean ± SEM).
(E) Changes in mRNA expression of inflammasome components and IL-1b
were assessed in the lungs over the course of influenza virus infection
(*p < 0.05; mean ± SEM). All experiments are representative of at least two
independent experiments with 3–5 mice per group.difference was observed between wild-type and Nlrp3/ mice
(Figure 2G). However, by 7 dpi. the Nlrp3/mice demonstrated
approximately 2-fold higher viral titer in the lungs than did the
wild-type animals (Figure 2G), providing evidence for a defect
in viral clearance in the absence of Nlrp3.
Nlrp3 Inflammasome Components Are Expressed
in the Lung and Myeloid Cells during Influenza Infection
To assess the relevance of Nlrp3 and Pycard in a panel of mouse
cells, we assayed expression by quantitative RT-PCR in primary
myeloid, lymphoid, and airway epithelial cells (Thompson et al.,
2006; Willingham et al., 2007). Under naive conditions, both
Nlrp3 and Pycard genes were highly expressed in primary
macrophages, and nominal expression was detected in T and
B lymphocytes (Figures 3A and 3B). In the mouse airway epithe-
lial cells (MAEC), only a low level of Pycard was detected, and
Nlrp3 was not found (Figures 3A and 3B).
To characterize the effects of viral infection on gene transcrip-
tion in these differentiated cell types, we challenged bone-
marrow-derived macrophages (BMMs) and MAECs with
influenza A/PR/8/34. No significant change in either Nlrp3 or
Nlrc4 transcription was observed after viral challenge in the
BMMs; however, a significant increase in IL-1b mRNA expres-
sion was detected (Figure 3C). In contrast, under naive condi-
tions, Nlrp3 expression was low in the MAECs. After influenza
infection, an increase in Nlrp3 transcription was observed,
whereas no significant changes were found in Nlrc4 and Il-1b
transcription (Figure 3D).
It should be noted that ex vivo cultured mouse BMMs were
refractory to influenza virus infection, as shown by the precipi-
tous drop in viral titer after exposure (Figure S2A). As a result
of the lack of a productive infection, we often observed inconsis-
tent IL-1b cytokine expression at theMOIs used in this study. For
this reason, we did not pursue additional experiments with
primary mouse macrophages. Even though IL-1b expression
was inconsistent, at MOIs greater than 10 we were able to
observe an increase in IFN-b at 12 hr, and we observed no differ-
ences between the genotypes (Figure S2B), indicating that the
genes studied did not affect IFN-b production.
To further assess the contribution of the NLRP3 inflamma-
some in vivo, we sought to assess changes in mRNA expression
of inflammasome components and IL-1b over a time course of
influenza virus infection. Total lung RNA was extracted from
tissue homogenates, and gene expression was assessed for
Nlrp3, Pycard, Il-1b, and caspase-1 (Figure 3E). A significant
increase in gene transcription was observed 3 dpi for all four as-
sessed mRNAs. This was followed by a significant reduction of
all mRNAs except caspase-1 by day 7 (Figure 3E). These results
indicate that influenza induced a substantial increase in all
components of the Nlrp3 inflammasome in the lungs and infil-
trating cells of inoculated animals 3 dpi and also indicate that
viral infection profoundly affects the inflammasome genes in
a way that alters their biologic function.
To determine the in vivo contribution of the macrophages in
the lungs of mice after virus infection, we harvested lungs 3 dpi
and visualized cells containing viral antigen by IHC and confocal
microscopy. The primary cells targeted in vivo in the mouse are
the airway epithelial cells (Figures S3A–S3C), and 15%ofmacro-
phages are the second largest population (Figures S3D–S3F).
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Figure 4. Mice Lacking Components of the Nlrp3 Inflammasome
Demonstrate Significantly Altered Levels of Proinflammatory
Cytokines after Pulmonary Challenge with Influenza
(A and B) IL-1b was assessed in serum (A) and BALF (B) from wild-type mock-
infected, wild-type influenza-infected, Nlrp3/, Nlrc4/, and Pycard/
mice, 3 days after infection.
(C–I) Serum levels of IL-18 were also determined in these animals (C). In addi-
tion to IL-1b and Il-18, MIP2a (D), KC (E), TNFa (F), IL-6 (G), IFNg (H), and IL-
12p40 (I) were also assessed (*p < 0.05; mean ± SEM). Mock, n = 5; Nlrp3/,
n = 6; Nlrc4/, n = 6; Pycard/, n = 9; wild-type, n = 5.
(J) Serum levels of IL-6 were determined 7 days after infection in wild-type
mock-infected, wild-type influenza-infected, and moribund Nlrp3/ mice
(*p < 0.05; mean ± SEM). Mock, n = 3; Nlrp3/, n = 6; wild-type, n = 3. All
data are representative of at least two independent experiments.However, a majority of macrophages and other leukocytes
present in the lungs of infected mice were IHC negative (Figures
S3G–S3I). Substantially smaller populations of polymorphonu-
clear cells and alveolar epithelial cells (<1%) were also infected
with virus (not shown). Together, these data suggest that airway
epithelial cells and macrophages are the likely cell types respon-
sible for mediating the innate immune response during the initial
stages of influenza virus infection.
NLRP3 Inflammasome Components Are Required
for Influenza-Induced Proinflammatory Mediator
Production
The above experiments indicate Nlrp3/ and Pycard/ mice
demonstrate attenuated airway inflammation and reduced560 Immunity 30, 556–565, April 17, 2009 ª2009 Elsevier Inc.survival after influenza virus infection. We next sought to assess
changes in serum and BALF cytokines known to play roles in
host immune responses to viruses. A significant increase in
IL-1b was detected in the serum and BALF from wild-type
animals. This increase was dependent on Nlrp3 and Pycard
but independent of Nlrc4 (Figures 4A and 4B). To demonstrate
that this lack of IL-1b was due to reduced post-translational
processing by the Nlrp3 inflammasome, we assessed lung
transcription of Il1b and observed significant increases in IL-1b
transcription in all mouse lines regardless of genotype
(Figure S4). As previously mentioned, IL-18 has also been shown
to be a critical mediator of influenza infection, and its maturation
also relies on NLR inflammasome activation. A significant
increase in serum IL-18 was detected in the wild-type mice
(Figure 4C). However, as with IL-1b, IL-18 was significantly
reduced to mock-infected amounts in mice lacking either Nlrp3
or Pycard (Figure 4C). KC, MIP2a, TNFa, IL-6, IFNg, and IL-12,
like IL-1b, facilitate a wide spectrum of immunologic functions
during respiratory virus infection. To evaluate these cytokine
concentrations in the lungs, we assessed the BALF supernatant
by ELISA. A significant decrease in MIP2a was also observed in
the Nlrp3/ and Pycard/ animals when they were compared
to wild-type animals (Figure 4D), and these results correlated
with the decreased cellularity observed in the BALF
(Figure 2D). Nlrp3/ mice also showed a modest decrease in
KC (Figure 4E). Pycard/ mice demonstrated a statistically
significant decrease in TNFa, and such a decrease was not
observed in the Nlrp3/ animals (Figure 4F). The observed
attenuation in TNFa in the Pycard/ animals was observed in
other assays and may reflect a previously-reported inflamma-
some-independent role for Pycard in the control of TNFa
(Taxman et al., 2006). No significant differences were observed
in IL-6, IFNg, or IL-12p40 after influenza infection among the
different mouse strains (Figures 4G–4I). Because of the
increased mortality observed in the Nlrp3/ mice, a subset of
moribund animals was harvested 7 dpi. BALF IL-6 concentra-
tions were significantly elevated in the Nlrp3/ mice compared
to the wild-type animals (Figure 4J). Although unexpected, this
observation is consistent with clinical findings in humans, where
influenza-infected individuals show increased IL-6 associated
with increased morbidity (Lee et al., 2007).
NLRP3 Inflammasome Activation in Response
to Influenza Is Dependent upon Lysosome Maturation
and ROS
For clinical relevance, the above study of mice required verifica-
tion in human cells. Airway epithelial cells are the predominant
cell type infected by influenza, and previous studies have
demonstrated that these cells contribute to innate immune
responses (Kato and Schleimer, 2007). Primary human airway
epithelial cell cultures (HAE) were infected with the human
influenza virus A/Victoria /3/75 (H3N2), and the supernatant
was harvested from either the apical or basolateral layer as previ-
ously described (Thompson et al., 2006). After infection, we
observed robust viral replication in the HAE cultures (data not
shown) and detected increased IL-1b concentrations in superna-
tant from the apical (Figure 5A) but not the basolateral layer. To
expand upon these findings, we infected a human nasal airway
epithelial cell line, JME, and observed increased NLRP3 and
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Figure 5. NLRP3 Inflammasome Activation in Response to the Influ-
enza Virus Is Dependent upon Lysosomal Maturation and ROS
Production in Human Cells
(A) IL-1b levels were determined in basolateral and apical washes from human
airway epithelial cells challenged with influenza A/Victoria/3/75 (Victoria) 48 hr
after infection (*p < 0.05; mean ± SEM).
(B) Human nasal airway epithelial cell lines (JME) were infected with A/Victoria/
3/75, and changes in NLRP3 and PYCARDmRNA expression were observed.
Data were normalized to 18 s and compared to the expression in similarly
treated human type II alveolar epithelial-like cell lines (A549).
(C) IL-1bwasmeasured in the supernatants from A/Victoria/3/75-infected JME
cells 24 hr after infection.
(D) Human THP-1 monocyte cell lines were infected with A/Victoria/3/75, and
IL-1b was measured in the supernatant over a 24 hr time course.
(E) Human THP-1 cells were infected with lentivirus containing shRNA for
PYCARD (shASC), NLRP3 (shNLRP3) or CARD8 (shTUCAN) or for a mutated
sh target sequence (shmut). IL-1b was assessed in cell-free supernatants
24 hr after infection (*p < 0.05; mean ± SEM).
(F) The effect of ZVAD-CHO and Ac-YVAD-CHO on IL-1b release was deter-
mined in THP-1 cells after influenza infection (*p < 0.05; mean ± SEM).
(G–I) IL-1b release by THP-1 cells after influenza infection was also assessed
after treatments with bafilomycin A (G), CA-074-Me (50 mM) and Cathepsin
K Inhibitor I (Cat K) (10 mM) (H), and (2R, 4R)-4-aminopyrrolidine-2-4-dicarbox-
ylate (APDC) (100 mM) and N-acetyl-L-cysteine (NAc)(50mM)(*p < 0.05; mean ±
SEM) (I). All data are representative of at least two independent experiments.
(J) The in vivo effect of NAc (250 mg/kg) on BALF IL-1b after influenza infection
was determined. (*p < 0.05; mean ± SEM). NAc mock, n = 1; NAc influenza,
n = 5, vehicle Influenza, n = 3.PYCARD expression (Figure 5B) and increased IL-1b release
(Figure 5C). In addition to the JME cell lines, A/Victoria also
induced a dramatic increase in IL-1b in a human monocytic
cell line (THP-1) (Figure 5D). These data indicate that human cells
of both monocytic and epithelial origin are contributors of IL-1b
during influenza virus infection.
To verify that influenza-virus-mediated IL-1b production in
THP-1 is dependent upon NLRP3 inflammasome components,
we utilized small heteroduplex RNA (shRNA) knockdown to
assess the contribution of NLRP3 and PYCARD. An shRNA
against the third putative inflammasome component, TUCAN
or CARDINAL (CARD8), was also targeted by shRNA. Successful
RNA reduction is shown in Figures S5A–S5C. These cells were
challenged with A/Victoria/3/75, and cell free supernatants
were collected over a 24 hr time-course. No differences in viral
titer were detected between the different knockdown and wild-
type cell lines 24 hr after infection (Figure S5D). When cytokine
was measured, a significant increase in IL-1b was observed in
the wild-type THP-1 cells and cells transfected with a scrambled
shRNA targeting sequence (shmut) 24 hr after infection, and this
increase was significantly attenuated in cells containing shRNA
targeting PYCARD and NLRP3, but not in those containing
shRNA targeting CARD8 (Figure 5E; Figure S5E). The role of
CARD8, a gene found in humans but not mice, has not been
previously studied by gene reduction. These data suggest that
the CARD8 protein may not be important for NLRP3 inflamma-
some function induced by influenza virus. To confirm the speci-
ficity of shNLRP3 in IL-1b production, we also assessed TNFa
release after influenza infection. As seen in Figure S5F, amounts
of TNFa were not reduced in cell lines with shNLRP3 but were
modestly reduced in cells with shASC, consistent with the
mouse data described earlier. Finally, we demonstrate that
ZVAD-CHO, a caspase inhibitor, and YVAD-CHO, a specific
peptide inhibitor of caspase-1, both attenuated IL-1b amounts
in a dose-dependent fashion after influenza virus infection
(Figure 5F).
To further explore the mechanism underlying IL-1b release in
response to influenza infection, we used pharmacological antag-
onist to block specific signaling pathways. Lysosomal degrada-
tion of particulate danger-associated molecular patterns
(DAMPs) has been shown to activate the NLRP3 inflammasome
(Hornung et al., 2008), but this has not been assessed in the
context of viral infection. To test this, we utilized bafilomycin A
to block lysosomal acidification via inhibition of the vacuolar H+
ATPase system. The addition of bafilomycin A at concentrations
used previously to inhibit DAMP signaling (Hornung et al.,
2008) completely abolished influenza-induced IL-1b release
(Figure 5G), which suggests a critical role for lysosomes in
virus-mediated NLRP3 inflammasome function. A specific lyso-
somal cysteine proteinase, cathepsin B, has been associated
with NLRP3-mediated cell death and IL-1b in response to
nonviral signals (Willingham et al., 2007; Hornung et al., 2008).
Utilizing the cathepsin B-specific inhibitor, Ca-074-Me, we
observed a significant attenuation in IL-1b release after influenza
challenge (Figure 5H). This suggests the importance of cathepsin
B in NLRP3-mediated response to influenza virus but also
suggests the involvement of additional lysosomal processes.
This decrease was not observed with specific inhibitors for
cathepsin K (Figure 5H). The release of lysosomal productsImmunity 30, 556–565, April 17, 2009 ª2009 Elsevier Inc. 561
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tion of ROS, and recent data have suggested that ROS genera-
tion by asbestos, monosodium urate and ATP is a necessary
step in inflammasome activation (Dostert et al., 2008). To test
whether this occurs during influenza virus infection, we treated
THP-1 cells with the ROS inhibitors N-acetyl-L-cysteine (NAc)
or (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (APDC) (Dos-
tert et al., 2008). Our data demonstrate attenuated IL-1b produc-
tion from cells treated with either ROS inhibitor (Figure 5I),
suggesting that ROS also contributes to NLRP3 inflammasome
activation in response to influenza.
Influenza infection in vivo results in a substantial increase in
ROS production in the airways of humans and mice. To assess
the physiological relevance of the in vitro ROS inhibitor findings,
we treatedmice with the ROS inhibitor NAc via intranasal admin-
istration as previously described (Springer et al., 2007). Similar to
the monocyte cell line findings, treatment with NAc completely
A B
C D
E F
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H
Figure 6. The NLRP3 Inflammasome Is Required for
Airway Inflammation Induced by Nucleic Acid Analogs
(A) Lungs were harvested 24 hr after poly(I:C) challenge.
Sections through the main bronchiole of the left lobe were
stained with H&E.
(B) Histological scoring of H&E-stained lung sections as shown
in (A) (*p < 0.05; **p < 0.01; mean ± SEM).
(C) BALF IL-1b was determined after poly(I:C) challenge in
wild-type, Nlrp3/, and mock-challenged wild-type mice
(*p < 0.05; mean ± SEM).
(D) The effect of PYCARD (shASC) and NLRP3 (shNLRP3)
shRNA knockdown on IL-1b release in response to poly(I:C)
in THP-1 cells was assessed (*p < 0.05; mean ± SEM).
(E) The effect of Ac-YVAD-CHO on IL-1b release was deter-
mined in THP-1 cells after poly(I:C) challenge (*p < 0.05;
mean ± SEM).
(F) IL-1b secretion stimulated by ssRNA40 was assessed after
the shRNA knockdown of PYCARD (shASC) and NLRP3
(shNLRP3) (*p < 0.05; mean ± SEM).
(G–I) IL-1b release following poly(I:C) stimulation in THP-1 cells
was assessed after treatmentswith bafilomycin A (100 nM) (G),
CA-074-Me (50 mM) (H), and (2R, 4R)-4-aminopyrrolidine-2-4-
dicarboxylate (APDC) (100 mM) and N-acetyl-L-cysteine (NAc)
(50 mM) (*p < 0.05; mean ± SEM) (I).
inhibited the generation of IL-1b in the BALF after
influenza infection (Figure 5J). In addition to NAc,
bafilomycin A and CA-074-MEwere also assessed;
however, the pharmacokinetics for each of these
compounds were not optimized for our in vivo
assessments (data not shown). Collectively, these
data suggest that NLRP3 inflammasome activation
in response to the virus occurswhen the cell senses
alterations of lysosomal content and ROS induction
in the cytosol after virus infection by using path-
ways similar to those activated by DAMPs.
Nlrp3 Mediates Airway Inflammation
and IL-1b Induction by the Viral RNA
Analogs poly(I:C) and ssRNA40
The data presented thus far demonstrate that Nlrp3
mediates in vivo airway inflammation in response to
influenza virus infection in mice and inflammasome
formation in bothmice and humans. To further explore themech-
anism underlying NLRP3 activation, we examine the in vivo
immune response to the viral RNA analog, poly(I:C). To assess
whether poly(I:C) is important for pulmonary inflammasome acti-
vation, mice were challenged intranasally with poly(I:C), and the
resultant airway inflammation was characterized. Poly(I:C)
induced moderate airway inflammation in the wild-type mice,
and inflammation was significantly reduced in the Nlrp3/
animals (Figure 6A). Nlrp3/ mice exposed to poly(I:C) showed
a significant reduction in the overall amount of airway inflamma-
tion (Figure 6B) and BALF IL-1b concentration (Figure 6C).
To verify this result in human cells, we utilized the shRNA
knockdown cell lines described above and demonstrate that
poly(I:C)-induced IL-1b is dependent on PYCARD and NLRP3
(Figure 6D). To confirm the role of caspase-1 in this mechanism,
we exposed cells to the caspase-1 inhibitor yVAD-CHO, which
significantly attenuated poly(I:C)-mediated IL-1b release
562 Immunity 30, 556–565, April 17, 2009 ª2009 Elsevier Inc.
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PYCARD-dependent IL-1b release was unique to poly(I:C), we
also stimulated cells with single-stranded GU-rich RNA
(ssRNA40) complexed with the cationic lipid LyoVec to facilitate
uptake. A significant NLRP3- and PYCARD-dependent increase
in IL-1b release was observed after ssRNA40 stimulation, indi-
cating that NLRP3 and PYCARD mediate responses to ssRNA
molecules (Figure 6F). To explore the intracellular pathways
that lead to NLRP3 activation by RNA analogs, we utilized phar-
macological inhibitors as described earlier and show that inflam-
masome activation in response to poly(I:C) requires lysosomal
maturation, cathepsin B, and the generation of ROS (Figures
6G–6I). Together, these data suggest that NLRP3 inflammasome
activation in response to virus is mediated by the recognition of
viral RNA and involves pathways associated with lysosomal
maturation and the induction of ROS.
DISCUSSION
In this report, we assess the in vivo contribution of NLRP3 to host
immune responses to viral infection. NLRP3 forms a multiprotein
inflammasome complex, which activates caspase-1 and leads
to the maturation of several key proinflammatory cytokines,
such as IL-1b and IL-18. It has been established that NLRP3
responds to both microbe-associated molecules and damage-
associated molecular patterns (DAMPS) such as uric acid,
alum salt, and silica (Dostert et al., 2008; Eisenbarth et al.,
2008; Hornung et al., 2008; Li et al., 2008; Martinon et al.,
2006). In all of these cases, it is clear that NLRP3 promotes
inflammation. A key question iswhetherNLRP3plays a beneficial
or pathogenic role. In this study, we clearly demonstrate that
NLRP3 and other components of the NLRP3 inflammasome
play a beneficial role in the in vivo innate immune response to
influenza infection and are required for normal host immune
responses to the virus. An examination of the mechanism by
which NLRP3 mediates host response to an RNA virus demon-
strates that recognition of RNA analogs or RNA molecules is
capable of mediating these responses. A further exploration of
the mechanism shows that similar to the activation of NLRP3
by DAMPs such as particulate alum, MSU crystals and silica,
activation of the NLRP3 pathway by the influenza virus, and
more specifically by RNA analogs, is dependent on an intact
lysosomal pathway and functional lysosomal enzymes such as
cathepsin B and is also reliant on ROS both in vitro and in vivo.
This supports the hypothesis that NLRP3 is activated through
common intracellular changes caused by either PAMPs or
DAMPs, rather than a model that evokes the direct interaction
of NLRP3 with ligands of diverse molecular structures.
The recognition of viral pathogens by cells of the innate
immune system is essential for the initiation of an ensuing inflam-
matory response. The endosomal TLRs TLR3, TLR7, and TLR8
and cytoplasmic RIG-I and MDA-5 are receptors of viral PAMPs
and the primary route for the elicitation of host immune
responses to viruses through the regulation of type-I interferons.
Among the NLR family, there are few reports linking these
proteins to the viral host response or viral pathogenesis. One
report identifies endogenous NLRX1 as an inhibitor of the RIG-I
and MDA-5 pathway through interactions with the essential
mitochondrial antiviral signaling adaptor (MAVS) (Moore et al.,2008). However, the in vivo importance of NLRX1 remains to
be determined. The involvement of NLRP3 in the macrophage
response to RNA viruses has been controversial. One study
has demonstrated the importance of Nlrp3 during viral infection
in culture (Kanneganti et al., 2006), whereas another group was
unable to confirm inflammasome activation after poly(I:C) chal-
lenge or infection with the RNA viruses reovirus and vesicular
stomatitis virus in culture. Although we did not assess reovirus
or VSV, our human monocytic cell line and in vivo mouse data
clearly show that NLRP3 and PYCARD are indeed required for
IL-1b maturation in response to influenza virus infection as well
as to dsRNA analogs and ssRNA. Therefore, our data support
the Kanneganti et al. study. However, we had difficulty studying
influenza viral infection of mouse macrophages ex vivo because
of a failure to establish a productive infection. Thus, we have not
precisely duplicated the ex vivo data observed by the first report.
A possible explanation that would reconcile the apparent
discrepancies in the field is that different NLRs might mediate
responses to different RNA viruses. The precedence for this is
provided by MDA5 and RIG-I, which recognize different types
of dsRNA and show viral specificity. RIG-I responds to RNA
viruses, including paramyxoviruses and influenza virus, whereas
MDA5 is essential for picornavirus recognition (Kato et al., 2008;
Kato et al., 2006). Thus, it is possible that NLRP3 is responsible
for dsRNA, ssRNA, DNA, Sendai virus, and influenza virus recog-
nition and that an unidentified NLR is activated by reovirus and
VSV.
Infection of mice with influenza virus results in a dramatic
increase inmorbidity andmortality andmimicsmany of the path-
ophysiological aspects of the human disease. The current study
shows that Pycard and Nlrp3 deficiencies reduce inflammation
in the lung, and this reduced inflammation is correlated with
increased mortality and a viral clearance defect. Thus, the
NLRP3 inflammasome-driven antiviral response is beneficial to
the host after influenza infection. Although the precise role for
both IL-1b and IL-18 in the immune response against viral path-
ogens remains elusive, in vivo assessments of IL-1R1- and
IL-18-deficient mice have shown that these animals have
reduced acute airway inflammation associated with influenza
virus infection and that both have significantly decreased
survival (Schmitz et al., 2005). These results are in agreement
with our findings. Our data also highlight the observation that
host response to influenza virus is specific and requires NLRP3
but not NLRC4. It should be noted that a recent study identified
a role for ASC and caspase-1, but not Nlrp3, in the initiation of
adaptive immunity against influenza virus (Ichinohe et al.,
2009). Similar to the findings presented here, Ichinohe et al.
demonstrate a role for both ASC and caspase-1 in mouse
survival and in vivo host immune responses to influenza virus
infection. Also similar to our findings, their data suggest that
Nlrp3 is responsible for recognition of influenza virus within the
alveolar macrophages and dendritic cells in a type I IFN-inde-
pendent manner in culture. Additionally, we have not extensively
assessed the establishment of CTL and IgA responses in our
report; however, our work shows that NLRP3 did not affect
IFN-g production during viral infection and agrees with their
observation that this gene does not affect adaptive immunity to
influenza virus. However, Ichinohe et al. fail to establish a role
for Nlrp3 in mouse survival and leukocyte recruitment to the
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ously published work and the data we present here. One obvious
difference between these publications is the subtle differences in
the virus preparation, which may explain some of the opposing
phenotypes.
Although our in vivo study shows that influenza virus is found
in both airway epithelial cells and macrophages in the mouse,
only mouse macrophages express detectable Nlrp3 transcript,
and they are thus the likely cell type mediating the beneficial
functions of host protection by Nlrp3. However, in humans we
find NLRP3 expression in both airway epithelial cells and macro-
phages and provide further evidence that NLRP3 and PYCARD
mediate inflammatory cytokine release in cells of human origin.
Thus, NLRP3 and PYCARD may play an even more profound
role in host inflammation and protection upon influenza infection
of humans. Considering the disastrous nature of a possible influ-
enza pandemic, our study suggests that targeting the NLRP3
inflammasome for enhanced function could become an impor-
tant therapeutic measure against such an infection.
EXPERIMENTAL PROCEDURES
Experimental Animals
All studies were conducted in accordancewith the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and the Institutional Animal
Care and Use Committee guidelines of University of North Carolina, Chapel
Hill. The generation of mice lacking functional Nlrp3 (Cryopyrin), Nlrc4
(ICE-Protease Activating Factor), Apoptotic Speck protein containing a Card
(Pycard), Casp1, and Myd88 has been previously described (Adachi et al.,
1998; Mariathasan et al., 2004; Sutterwala et al., 2006). The Nlrp3/ mice
were originally produced at Millenium Pharmceuticals, were kindly provided
by Dr. Richard Flavell as N5, and were backcrossed for another four genera-
tions at UNC-CH, resulting in mice that were backcrossed for a total of nine
generations.
Virus Propagation
Influenza virus A/PR/8/34 (H1N1) was propagated in the allantoic cavity of
10-day-old embryonated specific-pathogen-free chicken eggs and was
mouse adapted by a minimum of six serial passages through mice as previ-
ously described (Cottey et al., 2001). The influenza virus A/Victoria/3/75
(H3N2) is a recombinant virus generated from cloned cDNA in 293T cells
and propagated in MDCK cells. Viral titers were determined by standard
plaque assay on confluent monolayers of MDCK cells.
Influenza Virus Infection of Human Primary Cells and Cell Lines
Cells were challenged with A/Victoria (MOI = 1) for 2 hr at 37C. After incuba-
tion, supernatant was replaced with fresh media, and cells were incubated at
37C. Cell-free supernatants were harvested at select time points for viral titer
and cytokine analysis. To assess viral PAMPs, we incubated cells for 24 hr
in the presence of naked poly(I:C) (10 mg)(Sigma) or ssRNA40 complexed
with LyoVec (InvivoGen) (10 mg). For pharmacological assessments, cells
were treated with bafilomycin D (100–250 nM), Ac-ZVAD-CHO (10–100 mM),
Ac-ZVAD-CHO (10–100 mM), Ca-074-Me (10–50 mM), Cathepsin K Inhibitor I
(10–50 mM), N-acetyl-L-cysteine (NAC) (50–100 mM), or (2R, 4R)-4-aminopyr-
rolidine-2-4-dicarboxylate (APDC) (50–100 mM) as previously described (Dos-
tert et al., 2008; Hornung et al., 2008; Willingham et al., 2007).
In Vivo Influenza A Virus Infection and poly(I:C) Challenge
Animals were anesthetized and challenged by intranasal administration of
6 3 104 PFU/ml of influenza virus A/PR/8/34 in 50 ml of PBS and 0.1% alum
(Sigma). Mice were observed and weight was assessed daily for up to
14 dpi. For assessment of poly(I:C) in vivo, wild-type and NLRP3/ mice
received two doses (50 mg/dose) of poly(I:C) in 50 ml of PBS and 0.1% alum
or vehicle on alternating days and were harvested 24 hr after the second
administration. For assessment of in vivo ROS production, mice were treated564 Immunity 30, 556–565, April 17, 2009 ª2009 Elsevier Inc.with the ROS inhibitor NAc (250 mg/kg) via intranasal administration (as
previously described by Springer et al., 2007) throughout the course of virus
challenge.
Influenza-inoculated mice were euthanized either 3 or 7 dpi, and serum was
collected after cardiac puncture. Total cytokine levels were determined by
ELISA (R&D Biosystems or BD Biosciences). In some cases, bronchoalveolar
lavage (BAL) was performed, and the number of cells present in the BAL fluid
(BALF) was determined with a hemacytometer. A morphology-based differen-
tial cell count was conducted on cytospin preparations from the BALF and
stained with Diff-Quik solution (Sigma). BALF cellularity was also determined
via FACS with antibodies reactive to CD11b, CD11c, GR-1, B220, CD4, and
CD8 according to standard techniques. Centrifuging the remaining BALF
removed cells, and cytokine levels in the supernatant were determined.
For histopathologic examination, lungs were fixed by inflation and immer-
sion in 10% buffered formalin. To evaluate airway inflammation, we subjected
fixed lung slices to hematoxylin and eosin (H&E) staining. Evaluators who were
blinded to genotype and treatment scored lung sections (0 [none]–3 [extreme])
on the basis mononuclear and polymorphonuclear cell infiltration, perivascular
and peribronchiolar cuffing, and estimates of the percent of lung involved with
the inflammation.
For assessment of viral titer, whole lungs were removed, weighed, and
homogenized in PBS. Lung viral titers were determined by standard plaque
assay in the supernatants.
Statistical Analysis
Data are presented as the mean ± standard error of the mean (SEM). Analysis
of variance (ANOVA) followed by Tukey-Kramer HSD for multiple comparisons
was performed on complex data sets. Statistical significance for single data
points was assessed by the Student’s two-tailed t test. Survival curves were
generated via the product-limit method of Kaplan andMeier, and comparisons
were made via the log rank test. In all cases, a p value of less than 0.05 was
considered statistically significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.immunity.
com/supplemental/S1074-7613(09)00139-3.
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